Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

Journal of Clinical Oncology

Volumn 18, Issue 3, 2000, Pages 487-497

  van Leeuwen, Flora E ^a   Klokman, Willem J ^a   van't Veer, Mars B ^a   Hagenbeek, Anton ^a   Krol, Augustinus D G ^a   Vetter, Ursula A O ^a   Schaapveld, Michael ^a   van Heerde, Peter ^a   Burgers, J Marion V ^a   Somers, Reinier ^a   Aleman, Berthe M P ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; LOMUSTINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NETHERLANDS; PRIORITY JOURNAL; SECOND CANCER; SOLID TUMOR;

EID: 0033952110     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.3.487     Document Type: Article

References (51)

1. Urba WJ, Longo DL: Hodgkin's disease. N Engl J Med 326:678-687, 1992
2. Henry-Amar M, Joly F: Late complications after Hodgkin's disease. Ann Oncol 4:115-126, 1996
3. Arsenau JC, Sponzo RW, Levin DL, et al: Nonlymphomatous malignant tumors complicating Hodgkin's disease: Possible association with intensive therapy. N Engl J Med 287:1119-1122, 1972
4. Canellos GP, DeVita VT Jr, Arsenau JC: Second malignancies complicating Hodgkin's disease in remission. Lancet 1:947-949, 1975
5. Glicksman AS, Pajak TF, Gottlieb A, et al: Second malignant neoplasms in patients successfully treated for Hodgkin's disease: A Cancer and Leukemia Group B study. Cancer Treat Rep 66:1035-1044, 1982
6. Henry-Amar M: Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. J Natl Cancer Inst 71:911-916, 1983
7. Boivin JF, Hutchinson GB, Lyden M, et al: Second primary cancers following treatment of Hodgkin's disease. J Natl Cancer Inst 72:233-241, 1984
8. Tester WJ, Kinsella TJ, Waller B, et al: Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute's experience. J Clin Oncol 2:762-769, 1984
9. Valagussa P, Santoro A, Fossati-Bellani F, et al: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986
10. Pedersen-Bjergaard J, Larsen SO, Struck J, et al: Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease: Relation to age, cumulative dose of alkylating agents and time from chemotherapy. Lancet 2:83-88, 1987
11. Tucker MA, Coleman CN, Cox RS, et al: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81, 1988
12. Van Leeuwen FE, Somers R, Taal BG, et al: Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol 7:1046-1058, 1989
13. Henry-Amar M: Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Ann Oncol 3:S117-S128, 1992 (suppl 4)
14. Cimino G, Papa G, Tura S, et al: Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study. J Clin Oncol 9:432-437, 1991
15. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 304:1137-1143, 1992
16. Mauch PM, Kalish LA, Marcus KC, et al: Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87:3625-3632, 1996
17. Swerdlow AJ, Barber JA, Horwich A, et al: Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 75:116-123, 1997
18. Abrahamsen JF, Andersen A, Hannisdal E, et al: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 11:255-261, 1993
19. Van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
20. Boivin JF, Hutchison GB, Zauber AG, et al: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732-741, 1995
21. Kaldor JM, Day NE, Bell J, et al: Lung cancer following Hodgkin's disease: A case-control study. Int J Cancer 52:677-681, 1992
22. Krikorian JG, Burke JS, Rosenberg SA, et al: Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med 300:452-458, 1979
23. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
24. Tarbell NJ, Gelber RD, Weinstein HJ, et al: Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 341:1428-1432, 1993
25. Beaty O, Hudson MM, Greenwald C, et al: Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13:603-609, 1995
26. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries - Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 14:1442-1446, 1996
27. Jenkin D, Greenberg M, Fitzgerald A: Second malignant tumours in childhood Hodgkin's disease. Med Pediatr Oncol 26:373-379, 1996
28. Wolden SL, Lamborn KR, Cleary SF, et al: Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16:536-544, 1998
29. Carde P, Burgers JM, Henry-Amar M, et al: Clinical stages I and II Hodgkin's disease: A specifically tailored therapy according to prognostic factors - The 1977-1982 H5 controlled trials program. J Clin Oncol 6:239-252, 1988
30. Tubiana M, Henry-Amar M, Carde P, et al: Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease: The EORTC Lymphoma Group controlled clinical trials - 1964-1987. Blood 73:47-56, 1989
31. Somers R, Tubiana M, Henry-Amar M: EORTC lymphoma cooperative studies in clinical stage I-II Hodgkin's disease 1963-1987, in Diehl V, Pfreundschuh M, Loeffler M (eds): New Aspects in the Diagnosis and Treatment of Hodgkin's Disease. Berlin, Germany, Springer-Verlag, 1989, pp 175-181
32. Muir C, Waterhouse J, Mack T, et al (eds): Cancer Incidence in Five Continents (vol 5). IARC Scientific Publications no. 88. Lyon, France, International Agency for Research on Cancer, 1987
33. van der Sanden GAC, Coebergh JWW, Schouten LJ, et al: Cancer incidence in the Netherlands in 1989 and 1990: First results of the nationwide Netherlands cancer registry - Coordinating Committee for Regional Cancer Registries. Eur J Cancer 31A:1822-1829, 1995
34. Parkin DM, Whelan SL, Ferlay J, et al (eds): Cancer Incidence in Five Continents (vol 7). IARC Scientific Publications no. 143. Lyon, France, International Agency for Research on Cancer, 1997
35. Pearson ES, Hartley HO (eds): Biometrika Tables for Statisticians (ed 3). London, United Kingdom, Biometrika Trust, 1976
36. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
37. Cox DR: Regression models and life-tables. J R Stat Soc Ser B 334:187-202, 1972
38. Donaldson SS, Hancock SL: Second cancers after Hodgkin's disease in childhood. N Engl J Med 334:792-794, 1996 (editorial)
39. Swerdlow AJ, Douglas AJ, Vaughan Hudson G, et al: Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: Relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy. Br J Cancer 68:1006-1011, 1993
40. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31, 1993
41. Birdwell SH, Hancock SL, Varghese A, et al: Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 37:67-73, 1997
42. Griem ML, Kleinerman RA, Boice JD Jr, et al: Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 86:842-849, 1994
43. Land CE: Studies of cancer and radiation dose among atomic bomb survivors: The example of breast cancer. JAMA 274:402-407, 1995
44. Hancock SL, Cox RS, McDougall IR: Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599-605, 1991
45. Biti G, Cellai E, Magrini SM, et al: Second solid tumors and leukemia after treatment for Hodgkin's disease: An analysis of 1121patients from a single institution. Int J Radiat Oncol Biol Phys 29:25-31. 1994
46. Van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 87:1530-1537, 1995
47. Schilsky RL, Sherins RJ, Hubbard SM, et al: Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 71:552-556, 1981
48. Andrieu JM, Ochoa-Molina ME: Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer 52:435-438, 1983
49. Horning SJ, Hoppe RT, Kaplan HS, et al: Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 304: 1377-1382, 1981
50. Trichopoulos D, MacMahon B, Cole P: The menopause and breast cancer risk. J Natl Cancer Inst 48:605-613, 1972
51. Goss PE, Sierra S: Current perspectives on radiation-induced breast cancer. J Clin Oncol 16:338-347, 1998